SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 201.02+0.4%2:13 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jayhawk969 who wrote (24594)8/17/1998 9:03:00 AM
From: Henry Niman  Read Replies (1) of 32384
 
JD, As I said earlier, Ralf's analysis was flawed because he compared the last couple of years of LGND's deal with a few companies that he selected and he used the 6 year history of the companies (and of course ignored the fact that LGND also had a 6 year history).

In your case, your analysis is also flawed. BARS showed income for programs for which LGND already had partners, and they used 50 million shares in the calculations for 2006 to create a $14.55 EPS.

If LGND does a $200 million deal each year, the royalty and milestone payments would be markedly higher in 2006 than projected in the BARS' report, which of course was done by a well known company.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext